These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17050597)

  • 1. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells.
    Bobardt MD; Chatterji U; Selvarajah S; Van der Schueren B; David G; Kahn B; Gallay PA
    J Virol; 2007 Jan; 81(1):395-405. PubMed ID: 17050597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
    Saïdi H; Magri G; Nasreddine N; Réquena M; Bélec L
    Virology; 2007 Feb; 358(1):55-68. PubMed ID: 16934308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women.
    Andreoletti L; Skrabal K; Perrin V; Chomont N; Saragosti S; Gresenguet G; Moret H; Jacques J; Longo Jde D; Matta M; Mammano F; Belec L
    J Clin Microbiol; 2007 Jun; 45(6):1838-42. PubMed ID: 17460054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.
    Pastore C; Nedellec R; Ramos A; Pontow S; Ratner L; Mosier DE
    J Virol; 2006 Jan; 80(2):750-8. PubMed ID: 16378977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor.
    Chen J; Dang Q; Unutmaz D; Pathak VK; Maldarelli F; Powell D; Hu WS
    J Virol; 2005 Apr; 79(7):4140-9. PubMed ID: 15767415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
    Panos G; Watson DC
    Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.
    Singer II; Scott S; Kawka DW; Chin J; Daugherty BL; DeMartino JA; DiSalvo J; Gould SL; Lineberger JE; Malkowitz L; Miller MD; Mitnaul L; Siciliano SJ; Staruch MJ; Williams HR; Zweerink HJ; Springer MS
    J Virol; 2001 Apr; 75(8):3779-90. PubMed ID: 11264367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication.
    Lundquist CA; Zhou J; Aiken C
    J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium.
    Shen R; Drelichman ER; Bimczok D; Ochsenbauer C; Kappes JC; Cannon JA; Tudor D; Bomsel M; Smythies LE; Smith PD
    J Immunol; 2010 Apr; 184(7):3648-55. PubMed ID: 20208001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J; LaBranche CC; González-Scarano F
    J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5.
    Dolcini G; Derrien M; Chaouat G; Barré-Sinoussi F; Menu E
    AIDS Res Hum Retroviruses; 2003 Oct; 19(10):857-64. PubMed ID: 14585217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.
    Cammack N
    Antivir Chem Chemother; 1999 Mar; 10(2):53-62. PubMed ID: 10335399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates.
    Jansson M; Backström E; Scarlatti G; Björndal A; Matsuda S; Rossi P; Albert J; Wigzell H
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1405-14. PubMed ID: 11679153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.